Rosiglitazone-d3
CAS: 1132641-22-5
Ref. 3D-HVB64122
| 1mg | Ausgelaufen | ||
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen |
Produktinformation
Name:
Rosiglitazone-d3
Beschreibung:
Rosiglitazone-d3 is a synthetic analogue of pioglitazone. It is a PPARγ agonist that acts by binding to the receptor and activating it. Rosiglitazone-d3 has been shown to have an anti-inflammatory effect, which may be due to its ability to inhibit the activation of macrophages and neutrophils, suppress the secretion of inflammatory cytokines such as MCP-1, and reduce the expression of inflammatory genes in adipose tissue. This drug also has anti-thrombotic effects, which may be due to its ability to increase platelet adhesion and degranulation and promote angiogenesis.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
360.4 g/mol
Formel:
C18H19N3O3S
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
